## NKE: Nike, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 3.3% below STRENGTH zone (4.0-10.0%); PEG 2.62 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($64.16)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. State Street Corp Buys 1,590,603 Shares of NIKE, Inc. $NKE**
- Source: MarketBeat | 20251210T120859 | Bullish | Relevance: 98%
-  State Street Corp significantly increased its stake in NIKE, Inc. by purchasing over 1.59 million shares, bringing its total holdings to more than 59 million shares valued at over $4.2 billion. Other institutional investors have also adjusted their positions in NIKE, which has an average analyst rating of "Moderate Buy" and shows a recent dividend increase. Insider transactions include an EVP's sale of shares and a director's purchase of shares.

**2. 10 Consumer Discretionary Stocks With Whale Alerts In Today's Session**
- Source: Benzinga | 20251209T173846 | Neutral | Relevance: 84%
-  This article details significant options activity, dubbed "whale alerts," in ten consumer discretionary stocks. These alerts identify large-sum transactions that can signal future price movements, with comprehensive data provided for call and put options including sentiment, expiration dates, strike prices, total trade prices, open interest, and volume. The stocks highlighted include major companies like Tesla, Amazon, and Nike, among others.

**3. This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday**
- Source: Benzinga | 20251210T121619 | Bullish | Relevance: 72%
- Guggenheim analyst Simeon Siegel initiated coverage on Amazon.com, Inc. (NASDAQ: AMZN) with a Buy rating and a $300 price target. This article highlights five top analyst initiations for Wednesday, also including Samsara Inc. (NYSE: IOT), NIKE, Inc. (NYSE: NKE), Apogee Therapeutics, Inc. (NASDAQ: APGE), and ABM Industries Incorporated (NYSE: ABM), all receiving Buy or Overweight ratings with new price targets.

**4. Vision Capital Fund’s Views on Lululemon (LULU)**
- Source: Insider Monkey | 20251209T083900 | Somewhat-Bullish | Relevance: 64%
-  Vision Capital Fund shared its views on Lululemon Athletica Inc. (NASDAQ: LULU) in its Q3 2025 investor letter, noting weak earnings in Q1 and Q2 2025 due to headwinds in the US market and inventory issues. Despite strong growth in China, the fund suggests that while Lululemon is outperforming competitors like Nike, AI stocks might offer greater returns. Lululemon is not among their top 30 most popular stocks for hedge funds.

**5. Barclays initiates Amer Sports stock with Overweight rating, $49 target**
- Source: Investing.com | 20251209T080931 | Somewhat-Bullish | Relevance: 61%
- Barclays has initiated coverage on Amer Sports Inc. (NYSE:AS) with an Overweight rating and a $49 price target, citing its strong position in brand awareness and adoption, expected to drive above-industry average growth. The investment firm highlights growth opportunities for Arc’teryx and Salomon brands, along with strategic levers like direct-to-consumer expansion and geographic growth. This positive outlook is reinforced by Amer Sports' recent strong Q3 results and similar positive adjustments from other analyst firms.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Telsey Advisory | $75 | $75 | 0% |
| 2025-12-10 | Guggenheim | $77 | $0 | 0% |
| 2025-12-09 | Citigroup | $70 | $74 | -5% |
| 2025-11-13 | Wells Fargo | $75 | $60 | +25% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Telsey Advisory | main | Market Perform |
| 2025-12-10 | Guggenheim | init | Buy |
| 2025-12-09 | Citigroup | main | Neutral |
| 2025-11-13 | Wells Fargo | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($1.00M) |
| Sells | 4 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.7% (+1.3%)
- Blackrock Inc.: 7.7% (-0.1%)
- State Street Corpora: 4.9% (-1.9%)
- Capital World Invest: 3.5% (+0.7%)
- JPMORGAN CHASE & CO: 2.7% (+72.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +2.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.62 signals overvaluation risk, limited margin of safety. Forward P/E 26.7x attractive for 50% earnings growth. Quality metrics strong (ROE 21%). Balance sheet: strong liquidity (2.2x). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $100.1B |
| Beta | 1.29 |
| 52W Range | $52.28 - $82.44 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.62 |
| Forward P/E | 26.7 |
| Current P/E | 40.1 |
| YoY Growth | 50.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 1.1% to 3.3% (+2.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.7pp (needs >4.0% for momentum thesis). MRS_5 at 3.8% confirms short-term momentum alignment. AM_20 at 5.5% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.27% (CS: 66) | Neutral |
| RSI_14 | 60.4 | Neutral |
| MACD Histogram | 0.45 | Bullish |
| vs SMA20 | 1.054x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 1.002x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $67.74
- **Stop Loss:** $64.16 (5.3% risk)
- **Target:** $71.32 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 385
- **Position Value:** $26,079.90
- **Portfolio %:** 26.08%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2025-12-18 (Est: $0.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.27 | $0.49 | +84.5% |
| 2025Q2 | $0.12 | $0.14 | +13.5% |
| 2025Q1 | $0.28 | $0.54 | +94.9% |
| 2024Q4 | $0.63 | $0.78 | +23.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*